Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 9,490 |
| Other current assets | 110 |
| TOTAL | $9,600 |
| Non-Current Assets | |
| Other Non-Current Assets | 130 |
| TOTAL | $130 |
| Total Assets | $12,950 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 480 |
| Accrued Expenses | 1,020 |
| Other current liabilities | 2,830 |
| TOTAL | $5,050 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 160 |
| TOTAL | $2,440 |
| Total Liabilities | $7,510 |
| Shareholders' Equity | |
| Common Shares | 3 |
| Retained earnings | -16,250 |
| Other shareholders' equity | 17 |
| TOTAL | $5,440 |
| Total Liabilities And Equity | $12,950 |